top of page

News & Insights 

Assuring Your Patent And R&D Teams Are Well Connected

Updated: May 8


Biotech products and processes evolve over time. This can cause a misalignment between your issued/pending patent claims, and your improved processes and products. Thus, your patent team needs to stay closely connected to your R&D and product teams.


Are your patent, product and R&D teams well connected?


To find out, pose this question to your in-house IP coordinator/Chief patent counsel:

Has an experienced patent attorney confirmed that the claims of our issued patents/pending apps cover our current/improved products and processes?


This is also a great question that IP teams can ask themselves, to self assess. Since claim interpretation is complex, the question needs to be answered by an experienced patent attorney. You don't want to get surprised when a potential investor or acquirer discovers this misalignment during deal diligence.


At DHL, the quality and exceptional value of our life sciences IP work is the result of a much more intimate relationship with our clients made possible by an efficient, non-traditional business model that lets us set billable rates that are 25% to 50% below other top biotech patent law firms.


For more help in assessing your IP and IP team, check out our blog post: Is Your Patent Team Doing a Good Job in Building Your Patent Portfolio?





About DHL

Double Helix Law (DHL) has decades of experience building strong patent portfolios for life science companies. Learn more about DHL and meet the team.


Want to stay updated on life science patent law? Subscribe to get notified of updates





The content on this website (including all pages, articles, and comments) is not legal advice, and does not and is not intended to form or constitute any attorney-client relationship. The content is not a solicitation for business; it is for educational and entertainment purposes only, and reflects the personal views of the author(s) only and not those of any past, present, or future client of DHL. Any content should be double-checked for accuracy and current applicability, and liability is disclaimed for any error or omission.



5/08/25 Published (EJV)

Commentaires


Get the latest DHL news and life science patent and investor insights right in your mailbox!

Thanks for subscribing!

bottom of page